Metraipolis › archive › dc_4c74740bda59
PARP inhibitor YCH1899 activates type I interferon signaling and synergizes with STING agonists in BRCA-proficient tumors — Europe PMC PMID:42645640
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42645640
- DOI
- 10.1186/s43556-[numero omesso]-x
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T03:24:29.180Z
- SHA-256 of the archived text
e0f88a6c9b8b1ebf5367b4074447b91bf1ab5110ae4bf7c77ba09377be82ed1e- Stable URL of this page
https://metraipolis.com/documento/dc_4c74740bda59
How to cite
PARP inhibitor YCH1899 activates type I interferon signaling and synergizes with STING agonists in BRCA-proficient tumors — Europe PMC PMID:42645640 — Europe PMC (en), https://europepmc.org/article/MED/42645640 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4c74740bda59 (Metraipolis archive dc_4c74740bda59, sha256 e0f88a6c9b8b1ebf5367b4074447b91bf1ab5110ae4bf7c77ba09377be82ed1e)
BibTeX
@misc{dc4c74740bda59,
title = {PARP inhibitor YCH1899 activates type I interferon signaling and synergizes with STING agonists in BRCA-proficient tumors — Europe PMC PMID:42645640},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42645640},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4c74740bda59; sha256 e0f88a6c9b8b1ebf5367b4074447b91bf1ab5110ae4bf7c77ba09377be82ed1e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42645640. Agents can read the archived copy with the MCP tool read_document.